Azitra (AZTR) Prepaid Assets (2022 - 2026)

Azitra (AZTR) reported Prepaid Assets of $554646.0 for Q1 2026, down 1.27% on a YoY basis from $561798.0 in Q1 2025, and down 31.52% quarter-over-quarter from $809949.0 in Q4 2025.

Azitra (AZTR) Prepaid Assets (2022 - 2026) Analysis & Trends

Azitra has reported Prepaid Assets for 5 years, with the latest figure at $554646.0 in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets fell 1.27% year-over-year to $554646.0; the trailing twelve-month figure through Mar 2026 stood at $554646.0 (down 1.27% YoY), and the FY2025 full-year result was $809949.0, up 42.7% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $554646.0, down from $809949.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $812159.0 in Q3 2025, with the low at $48523.0 in Q2 2023.
  • Historically, Prepaid Assets has averaged $474890.8 across 5 years, with a median of $448257.0 in 2023.
  • The largest YoY upside for Prepaid Assets was 679.05% in 2024 against a maximum downside of 10.87% in 2024.
  • Azitra's Prepaid Assets stood at $160133.0 in 2022, then soared by 179.93% to $448257.0 in 2023, then increased by 26.62% to $567569.0 in 2024, then surged by 42.7% to $809949.0 in 2025, then slumped by 31.52% to $554646.0 in 2026.
  • The last three Prepaid Assets figures came in at $554646.0 (Q1 2026), $809949.0 (Q4 2025), and $812159.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Azitra 20,900.00 20,900.00 -

Historic Data

Download Data
DateValue
Mar 31, 2026 554,646.00
Dec 31, 2025 809,949.00
Sep 30, 2025 812,159.00
Jun 30, 2025 675,553.00
Mar 31, 2025 561,798.00
Dec 31, 2024 567,569.00
Sep 30, 2024 364,673.00
Jun 30, 2024 378,019.00
Mar 31, 2024 383,131.00
Dec 31, 2023 448,257.00
Sep 30, 2023 409,170.00
Jun 30, 2023 48,523.00
Dec 31, 2022 160,133.00